<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>小药说药 | wechat-feeds</title><link>http://MzAxMDMyMTQwMA.favicon.privacyhide.com/favicon.ico</link><description>姓药的来说药，带你进入最深层次的医药领域，把握医药动态，了解最新前沿！</description><managingEditor> (hellodword)</managingEditor><pubDate>Tue, 15 Jun 2021 07:18:40 +0800</pubDate><image><url>http://MzAxMDMyMTQwMA.favicon.privacyhide.com/favicon.ico</url><title>小药说药 | wechat-feeds</title><link>http://MzAxMDMyMTQwMA.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>ADC的临床药理学简述</title><link>https://mp.weixin.qq.com/s/nUzJoyn5bckz4DlgqbQmdA</link><description></description><content:encoded><![CDATA[ADC的临床药理学简述]]></content:encoded><pubDate>Tue, 15 Jun 2021 06:32:04 +0800</pubDate></item><item><title>mRNA疫苗技术创新</title><link>https://mp.weixin.qq.com/s/2b7EH4wfiDpK3LoTMLc0_A</link><description></description><content:encoded><![CDATA[mRNA疫苗技术创新]]></content:encoded><pubDate>Mon, 14 Jun 2021 06:28:50 +0800</pubDate></item><item><title>个性化新抗原肿瘤疫苗的研究进展和挑战</title><link>https://mp.weixin.qq.com/s/BWNDQzoqLD4wsOiriQWfwQ</link><description></description><content:encoded><![CDATA[个性化新抗原肿瘤疫苗的研究进展和挑战]]></content:encoded><pubDate>Mon, 14 Jun 2021 06:28:50 +0800</pubDate></item><item><title>人工智能与药物研发</title><link>https://mp.weixin.qq.com/s/7f6PYli6nGR8MJimXPmK6A</link><description></description><content:encoded><![CDATA[人工智能与药物研发]]></content:encoded><pubDate>Sun, 13 Jun 2021 06:18:14 +0800</pubDate></item><item><title>药物发现中的人工智能：关于物理数据和生物数据的讨论</title><link>https://mp.weixin.qq.com/s/FhUGW6bBM25q7fZWH0jc_A</link><description></description><content:encoded><![CDATA[药物发现中的人工智能：关于物理数据和生物数据的讨论]]></content:encoded><pubDate>Sun, 13 Jun 2021 06:18:14 +0800</pubDate></item><item><title>精准医学在癌症研究的关键差距与机遇</title><link>https://mp.weixin.qq.com/s/qvi_UQVEUgcPD9mqfBJKjg</link><description></description><content:encoded><![CDATA[精准医学在癌症研究的关键差距与机遇]]></content:encoded><pubDate>Sat, 12 Jun 2021 07:05:58 +0800</pubDate></item><item><title>靶向抗癌药物的免疫调节作用</title><link>https://mp.weixin.qq.com/s/JpUpVk5a84zJ_tydm1WL2w</link><description></description><content:encoded><![CDATA[靶向抗癌药物的免疫调节作用]]></content:encoded><pubDate>Sat, 12 Jun 2021 07:05:58 +0800</pubDate></item><item><title>肿瘤免疫治疗的抗体如何选择亚型？</title><link>https://mp.weixin.qq.com/s/IDz_6ZQ_VymhlATM3rR-3A</link><description></description><content:encoded><![CDATA[肿瘤免疫治疗的抗体如何选择亚型？]]></content:encoded><pubDate>Fri, 11 Jun 2021 06:27:52 +0800</pubDate></item><item><title>盘点2021上市的抗体新药-（5）aducanumab-avwa</title><link>https://mp.weixin.qq.com/s/tfTKxQt2PCfIy4AH6sw8tA</link><description></description><content:encoded><![CDATA[盘点2021上市的抗体新药-（5）aducanumab-avwa]]></content:encoded><pubDate>Fri, 11 Jun 2021 06:27:52 +0800</pubDate></item><item><title>抗体药物的免疫原性</title><link>https://mp.weixin.qq.com/s/fHiwpfrkTEROwwgkkk7efA</link><description></description><content:encoded><![CDATA[抗体药物的免疫原性]]></content:encoded><pubDate>Thu, 10 Jun 2021 06:38:36 +0800</pubDate></item><item><title>ADC的免疫原性</title><link>https://mp.weixin.qq.com/s/gPEQeg4GHu9QKTPu_N4ovw</link><description></description><content:encoded><![CDATA[ADC的免疫原性]]></content:encoded><pubDate>Thu, 10 Jun 2021 06:38:36 +0800</pubDate></item><item><title>重磅！Aducanumab获FDA加速批准， 全球阿尔茨海默症研发管线迎利好！</title><link>https://mp.weixin.qq.com/s/Ebbu5gi3tg6n2DY88dp-8g</link><description></description><content:encoded><![CDATA[重磅！Aducanumab获FDA加速批准， 全球阿尔茨海默症研发管线迎利好！]]></content:encoded><pubDate>Wed, 09 Jun 2021 06:32:20 +0800</pubDate></item><item><title>新型免疫检查点抑制剂的临床观察</title><link>https://mp.weixin.qq.com/s/gOmtqd-g6HFpt8IdcYh58w</link><description></description><content:encoded><![CDATA[新型免疫检查点抑制剂的临床观察]]></content:encoded><pubDate>Tue, 08 Jun 2021 06:20:25 +0800</pubDate></item><item><title>自身免疫与炎症性疾病生物疗法三十年来的经验总结</title><link>https://mp.weixin.qq.com/s/IL_2zUATpXPz0zHoIxvSKA</link><description></description><content:encoded><![CDATA[自身免疫与炎症性疾病生物疗法三十年来的经验总结]]></content:encoded><pubDate>Mon, 07 Jun 2021 06:22:38 +0800</pubDate></item><item><title>自身免疫疾病的生物学与临床研究进展</title><link>https://mp.weixin.qq.com/s/9KJBGJdTObsOa0OfVwN13g</link><description></description><content:encoded><![CDATA[自身免疫疾病的生物学与临床研究进展]]></content:encoded><pubDate>Mon, 07 Jun 2021 06:22:38 +0800</pubDate></item><item><title>GPCR抗体药物的研发进展</title><link>https://mp.weixin.qq.com/s/HJbEqivB-k6JSe8CYbENeg</link><description></description><content:encoded><![CDATA[GPCR抗体药物的研发进展]]></content:encoded><pubDate>Sun, 06 Jun 2021 06:34:27 +0800</pubDate></item><item><title>靶向GPCR受体复合物：药物发现的新方向</title><link>https://mp.weixin.qq.com/s/PDcWyLjn79jc6S3E1lsPzg</link><description></description><content:encoded><![CDATA[靶向GPCR受体复合物：药物发现的新方向]]></content:encoded><pubDate>Sun, 06 Jun 2021 06:34:27 +0800</pubDate></item><item><title>GPCR的偏向配体</title><link>https://mp.weixin.qq.com/s/O5-rREHeB_ji5u7qm_r_Bw</link><description></description><content:encoded><![CDATA[GPCR的偏向配体]]></content:encoded><pubDate>Sun, 06 Jun 2021 06:34:27 +0800</pubDate></item><item><title>GPCR药物靶点的自然遗传变异</title><link>https://mp.weixin.qq.com/s/K70laQatAuOCc6LkcY15cA</link><description></description><content:encoded><![CDATA[GPCR药物靶点的自然遗传变异]]></content:encoded><pubDate>Sun, 06 Jun 2021 06:34:27 +0800</pubDate></item></channel></rss>